Package 42708-172-20

Brand: cyclobenzaprine hydrochloride

Generic: cyclobenzaprine hydrochloride
NDC Package Sample

Package Facts

Identity

Package NDC 42708-172-20
Digits Only 4270817220
Product NDC 42708-172
Description

20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (42708-172-20)

Marketing

Marketing Status
Marketed Since 2023-05-19
Brand cyclobenzaprine hydrochloride
Generic cyclobenzaprine hydrochloride
Sample Package Yes

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "459bb393-8b6b-f9b9-e063-6294a90ad73c", "openfda": {"unii": ["0VE05JYS2P"], "rxcui": ["828320"], "spl_set_id": ["fbe6ba88-0581-50ef-e053-6394a90ab086"], "manufacturer_name": ["QPharma Inc"]}, "finished": true, "packaging": [{"sample": true, "description": "20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (42708-172-20)", "package_ndc": "42708-172-20", "marketing_start_date": "20230519"}], "brand_name": "Cyclobenzaprine Hydrochloride", "product_id": "42708-172_459bb393-8b6b-f9b9-e063-6294a90ad73c", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Centrally-mediated Muscle Relaxation [PE]", "Muscle Relaxant [EPC]"], "product_ndc": "42708-172", "generic_name": "Cyclobenzaprine Hydrochloride", "labeler_name": "QPharma Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cyclobenzaprine Hydrochloride", "active_ingredients": [{"name": "CYCLOBENZAPRINE HYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "ANDA078643", "marketing_category": "ANDA", "marketing_start_date": "20080926", "listing_expiration_date": "20261231"}